Nicolas Gazeau

Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

Nicolas Gazeau, Emily C. Liang, Qian Wu et al. · Transplantation and Cellular Therapy · 2023 · 114 citations · Full text

Inflammation, Autoimmune Disease, Medicine +10

Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL

Jordan Gauthier, Nicolas Gazeau, Alexandre V. Hirayama et al. · Blood · 2022 · 48 citations · Full text

Effective anti-BCMA retreatment in multiple myeloma

Nicolas Gazeau, David Beauvais, Ibrahim Yakoub‐Agha et al. · Blood Advances · 2021 · 44 citations · Full text

Hematological Malignancy, Autoimmune Disease, Bcma Expression +11

Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma

Alexandre V. Hirayama, Erik L. Kimble, Jocelyn H. Wright et al. · Blood Advances · 2023 · 43 citations · Full text

Immunology, Immunoediting, Immunotherapeutics +21

Safety and Efficacy of Two Anakinra Dose Regimens for Refractory CRS or Icans after CAR T-Cell Therapy

Nicolas Gazeau, Pere Barba, Gloria Iacoboni et al. · Blood · 2021 · 18 citations